BENZIMIDAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE

Compounds of formula (I): (I) [wherein: X represents an optionally substituted benzimidazole group; Y represents an oxygen or sulfur atom; Z represents a 2,4-dioxothiazolidin-5-ylidenyl-methyl, 2,4-dioxothiazolidin-5-ylmethyl, 2,4-dioxo-oxazolidin-5-ylmethyl, 3,5-dioxooxadiazolidin-2-ylmethyl or N-h...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: YANAGISAWA, HIROAKI, HORIKOSHI, HIROYOSHI, FUJIWARA, TOSHIHIKO, FUJITA, TAKASHI, WADA, KUNIO, OGUCHI, MINORU, FUJIMOTO, KOICHI, YOSHIOKA, TAKAO
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator YANAGISAWA, HIROAKI
HORIKOSHI, HIROYOSHI
FUJIWARA, TOSHIHIKO
FUJITA, TAKASHI
WADA, KUNIO
OGUCHI, MINORU
FUJIMOTO, KOICHI
YOSHIOKA, TAKAO
description Compounds of formula (I): (I) [wherein: X represents an optionally substituted benzimidazole group; Y represents an oxygen or sulfur atom; Z represents a 2,4-dioxothiazolidin-5-ylidenyl-methyl, 2,4-dioxothiazolidin-5-ylmethyl, 2,4-dioxo-oxazolidin-5-ylmethyl, 3,5-dioxooxadiazolidin-2-ylmethyl or N-hydroxyureidomethyl group; R represents hydrogen, alkyl, alkoxy, halogen, hydroxy, nitro, amino or aralkyl; and m is an integer from 1 to 5]; have valuable activity for the treatment and/or prophylaxis of a variety of disorders, including one or more of: hyperlipemia, hyperglycemia, obesity, impaired glucose tolerance (IGT), insulin resistance and diabetic complications.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA2177858C</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA2177858C</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA2177858C3</originalsourceid><addsrcrecordid>eNrjZHBzcvWL8vT1dHGM8vdxVXBxDfIMcwzxDHMN1lEI8XD1DFIICHINcAwCivn7KTj6uUBFgWSQY4BraIins0JosCsPA2taYk5xKi-U5maQd3MNcfbQTS3Ij08tLkhMTs1LLYl3djQyNDe3MLVwNiasAgAkEyu5</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>BENZIMIDAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE</title><source>esp@cenet</source><creator>YANAGISAWA, HIROAKI ; HORIKOSHI, HIROYOSHI ; FUJIWARA, TOSHIHIKO ; FUJITA, TAKASHI ; WADA, KUNIO ; OGUCHI, MINORU ; FUJIMOTO, KOICHI ; YOSHIOKA, TAKAO</creator><creatorcontrib>YANAGISAWA, HIROAKI ; HORIKOSHI, HIROYOSHI ; FUJIWARA, TOSHIHIKO ; FUJITA, TAKASHI ; WADA, KUNIO ; OGUCHI, MINORU ; FUJIMOTO, KOICHI ; YOSHIOKA, TAKAO</creatorcontrib><description>Compounds of formula (I): (I) [wherein: X represents an optionally substituted benzimidazole group; Y represents an oxygen or sulfur atom; Z represents a 2,4-dioxothiazolidin-5-ylidenyl-methyl, 2,4-dioxothiazolidin-5-ylmethyl, 2,4-dioxo-oxazolidin-5-ylmethyl, 3,5-dioxooxadiazolidin-2-ylmethyl or N-hydroxyureidomethyl group; R represents hydrogen, alkyl, alkoxy, halogen, hydroxy, nitro, amino or aralkyl; and m is an integer from 1 to 5]; have valuable activity for the treatment and/or prophylaxis of a variety of disorders, including one or more of: hyperlipemia, hyperglycemia, obesity, impaired glucose tolerance (IGT), insulin resistance and diabetic complications.</description><language>eng ; fre</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2010</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20100706&amp;DB=EPODOC&amp;CC=CA&amp;NR=2177858C$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20100706&amp;DB=EPODOC&amp;CC=CA&amp;NR=2177858C$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>YANAGISAWA, HIROAKI</creatorcontrib><creatorcontrib>HORIKOSHI, HIROYOSHI</creatorcontrib><creatorcontrib>FUJIWARA, TOSHIHIKO</creatorcontrib><creatorcontrib>FUJITA, TAKASHI</creatorcontrib><creatorcontrib>WADA, KUNIO</creatorcontrib><creatorcontrib>OGUCHI, MINORU</creatorcontrib><creatorcontrib>FUJIMOTO, KOICHI</creatorcontrib><creatorcontrib>YOSHIOKA, TAKAO</creatorcontrib><title>BENZIMIDAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE</title><description>Compounds of formula (I): (I) [wherein: X represents an optionally substituted benzimidazole group; Y represents an oxygen or sulfur atom; Z represents a 2,4-dioxothiazolidin-5-ylidenyl-methyl, 2,4-dioxothiazolidin-5-ylmethyl, 2,4-dioxo-oxazolidin-5-ylmethyl, 3,5-dioxooxadiazolidin-2-ylmethyl or N-hydroxyureidomethyl group; R represents hydrogen, alkyl, alkoxy, halogen, hydroxy, nitro, amino or aralkyl; and m is an integer from 1 to 5]; have valuable activity for the treatment and/or prophylaxis of a variety of disorders, including one or more of: hyperlipemia, hyperglycemia, obesity, impaired glucose tolerance (IGT), insulin resistance and diabetic complications.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2010</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHBzcvWL8vT1dHGM8vdxVXBxDfIMcwzxDHMN1lEI8XD1DFIICHINcAwCivn7KTj6uUBFgWSQY4BraIins0JosCsPA2taYk5xKi-U5maQd3MNcfbQTS3Ij08tLkhMTs1LLYl3djQyNDe3MLVwNiasAgAkEyu5</recordid><startdate>20100706</startdate><enddate>20100706</enddate><creator>YANAGISAWA, HIROAKI</creator><creator>HORIKOSHI, HIROYOSHI</creator><creator>FUJIWARA, TOSHIHIKO</creator><creator>FUJITA, TAKASHI</creator><creator>WADA, KUNIO</creator><creator>OGUCHI, MINORU</creator><creator>FUJIMOTO, KOICHI</creator><creator>YOSHIOKA, TAKAO</creator><scope>EVB</scope></search><sort><creationdate>20100706</creationdate><title>BENZIMIDAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE</title><author>YANAGISAWA, HIROAKI ; HORIKOSHI, HIROYOSHI ; FUJIWARA, TOSHIHIKO ; FUJITA, TAKASHI ; WADA, KUNIO ; OGUCHI, MINORU ; FUJIMOTO, KOICHI ; YOSHIOKA, TAKAO</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA2177858C3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2010</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>YANAGISAWA, HIROAKI</creatorcontrib><creatorcontrib>HORIKOSHI, HIROYOSHI</creatorcontrib><creatorcontrib>FUJIWARA, TOSHIHIKO</creatorcontrib><creatorcontrib>FUJITA, TAKASHI</creatorcontrib><creatorcontrib>WADA, KUNIO</creatorcontrib><creatorcontrib>OGUCHI, MINORU</creatorcontrib><creatorcontrib>FUJIMOTO, KOICHI</creatorcontrib><creatorcontrib>YOSHIOKA, TAKAO</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>YANAGISAWA, HIROAKI</au><au>HORIKOSHI, HIROYOSHI</au><au>FUJIWARA, TOSHIHIKO</au><au>FUJITA, TAKASHI</au><au>WADA, KUNIO</au><au>OGUCHI, MINORU</au><au>FUJIMOTO, KOICHI</au><au>YOSHIOKA, TAKAO</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>BENZIMIDAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE</title><date>2010-07-06</date><risdate>2010</risdate><abstract>Compounds of formula (I): (I) [wherein: X represents an optionally substituted benzimidazole group; Y represents an oxygen or sulfur atom; Z represents a 2,4-dioxothiazolidin-5-ylidenyl-methyl, 2,4-dioxothiazolidin-5-ylmethyl, 2,4-dioxo-oxazolidin-5-ylmethyl, 3,5-dioxooxadiazolidin-2-ylmethyl or N-hydroxyureidomethyl group; R represents hydrogen, alkyl, alkoxy, halogen, hydroxy, nitro, amino or aralkyl; and m is an integer from 1 to 5]; have valuable activity for the treatment and/or prophylaxis of a variety of disorders, including one or more of: hyperlipemia, hyperglycemia, obesity, impaired glucose tolerance (IGT), insulin resistance and diabetic complications.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_CA2177858C
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title BENZIMIDAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T03%3A12%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=YANAGISAWA,%20HIROAKI&rft.date=2010-07-06&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA2177858C%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true